Mark Brosius Sells 2,128 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 2,128 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at $140,595. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Thursday, October 24th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The shares were sold at an average price of $510.79, for a total value of $11,237.38.
• On Thursday, September 12th, Mark Brosius sold 2,115 shares of Intuitive Surgical stock. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $0.95 on Thursday, reaching $511.63. The stock had a trading volume of 755,379 shares, compared to its average volume of 1,471,841. The firm has a market capitalization of $181.48 billion, a price-to-earnings ratio of 92.35, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. The company has a 50-day simple moving average of $486.71 and a 200-day simple moving average of $440.96. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $523.34.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Brookstone Capital Management increased its holdings in shares of Intuitive Surgical by 17.2% in the 1st quarter. Brookstone Capital Management now owns 10,241 shares of the medical equipment provider’s stock worth $4,087,000 after purchasing an additional 1,505 shares in the last quarter. DGS Capital Management LLC grew its holdings in shares of Intuitive Surgical by 47.1% in the first quarter. DGS Capital Management LLC now owns 1,275 shares of the medical equipment provider’s stock worth $509,000 after acquiring an additional 408 shares during the period. Janiczek Wealth Management LLC lifted its position in Intuitive Surgical by 17.2% during the first quarter. Janiczek Wealth Management LLC now owns 708 shares of the medical equipment provider’s stock valued at $283,000 after purchasing an additional 104 shares in the last quarter. Procyon Advisors LLC lifted its position in Intuitive Surgical by 4.3% during the first quarter. Procyon Advisors LLC now owns 5,581 shares of the medical equipment provider’s stock valued at $2,227,000 after purchasing an additional 228 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Intuitive Surgical by 4.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 156,456 shares of the medical equipment provider’s stock valued at $62,440,000 after purchasing an additional 6,712 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on ISRG. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Leerink Partners raised their price target on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Citigroup raised their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Barclays raised their price target on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Finally, Truist Financial increased their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.